Welcome!

News Feed Item

Interventional Oncology -- Combinational Technologies Play a Crucial Role for the European Outlook

LONDON, July 10, 2013 /PRNewswire/ -- A decade ago, there was little interest in interventional cancer therapies. Five years ago, newly diagnosed cases of different types of cancer stood at about 12.7 million with 7.6 million related deaths registered. According to the WHO GLOBOCAN database, the top three diagnosed cancer forms in 2008 included lung – 1.61 million, breast – 1.38 million, and colorectal – 1.23 million, while the most common types of cancer with leading death rate were lung – 1.38 million, stomach – 0.74 million, and liver – 0.69 million.

These alarming statistics have made interventional oncology a rapidly evolving speciality. Traditional surgical techniques are now increasingly being replaced by minimally invasive imaging-guided procedures. Primary interventional techniques include thermal ablation, high intensity focused ultrasound (HIFU), and embolization.

Radiofrequency ablation (RFA) and cryoablation are already considered sound treatment options, while transarterial chemoembolization (TACE) is probably the worldwide standard for treatment of unresectable hepatocellular carcinoma, with drug-eluting beads being the first major technology advancement in TACE. Microwave ablation (MWA), irreversible electroporation, and HIFU are evolving interventional technologies.

"The popularity of interventional technology is increasing; looking into the future, the medical fraternity is considering it as a major treatment possibility," said Frost & Sullivan Healthcare Senior Analyst Akanksha Joshi. "Cost effectiveness and improvement in quality of life are the main merits achieved with interventional oncology."

Although surgery remains the standard treatment method for most forms of cancer, there is ample space for new technologies to be implemented. MWA has introduced advantages over RFA and is steadily growing in sales. Selective internal radiation therapy (SIRT) and HIFU too are gaining ground due to clear benefits like targeted therapy and non-invasiveness, respectively.

"Presented as the most accurate and patient-friendly procedures that are applicable to a wide patient base, TACE, HIFU and SIRT are in the growth phases and likely to gain a much larger market share in the future," noted Joshi. "Unfortunately, treatment methods using ablation technologies and SIRT have little or no reimbursement in Europe despite the clear demand for minimally invasive and non-invasive methods that increase patient comfort, reduce patient hospital stay, and hence decrease treatment costs for both hospitals and patients. Surgery continues to be the trusted and globally reimbursed mode of treatment for cancer."

Further, full clinical evidence for the effective use of new technologies is still lacking. Most studies are vendor sponsored which means parameters to evaluate the device vary and results may thus not be unbiased.

Increasing investment in research will improve existing devices and technologies' output. For instance, tissue overheating during MWA may be avoided by implementing power control algorithms, and advanced ergonomic devices are being designed with instinctive controls and features.

Manufacturers will greatly benefit from the fact that many interventional oncology technologies can be used as combinational technology. Numerous possibilities have been researched, such as heat activated liposomal doxorubicin with RFA. Similarly, both HIFU and RFA help in the deposition of doxorubicin. Studies also indicate that the combination of technologies such as RFA with TACE, or percutaneous ethanol injection (PEI) with RFA or TACE provides better-quality treatment. Clinical trials are currently being performed to prove the efficacy of such combined technologies.

"Availability of reimbursement for interventional oncology technologies would make them more popular as combinational technologies," stressed Joshi. "This trend would favour the use of different techniques as per necessity and benefit of patients."

Going forward, image-guided multimodality routing, computerisation and visualisation, along with electromagnetic radiation, drug delivery and immunotherapy, are expected to play a pivotal role in curing cancerous tissues. Methods gaining popularity in this treatment space include image-guided stereotactic radiotherapy with modern methods of respiratory synchronization.

For now, combinational technology will offer medical oncologists a choice of additional treatment, although there still remains a need to search for a technology that can substitute surgery. Collaboration between the science and medical communities, and manufacturers will pave the way for an effective treatment solution.

If you are interested in more information on this Market Insight on Interventional Oncology – Combinational Technologies, please send an email to Anna Zanchi, Corporate Communications, at [email protected]

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion
Join Us:           Join our community
Subscribe:       Newsletter on "the next big thing"
Register:         Gain access to visionary innovation

Contact
Anna Zanchi
Corporate Communications – Europe
P: +39.02.4851 6133
E: [email protected]
http://www.frost.com

SOURCE Frost & Sullivan

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Ovum, a leading technology analyst firm, has published an in-depth report, Ovum Decision Matrix: Selecting a DevOps Release Management Solution, 2016–17. The report focuses on the automation aspects of DevOps, Release Management and compares solutions from the leading vendors.
Continuous testing helps bridge the gap between developing quickly and maintaining high quality products. But to implement continuous testing, CTOs must take a strategic approach to building a testing infrastructure and toolset that empowers their team to move fast. Download our guide to laying the groundwork for a scalable continuous testing strategy.
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle. In his session at 18th Cloud Expo, ...
SYS-CON Events announced today that LeaseWeb USA, a cloud Infrastructure-as-a-Service (IaaS) provider, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LeaseWeb is one of the world's largest hosting brands. The company helps customers define, develop and deploy IT infrastructure tailored to their exact business needs, by combining various kinds cloud solutions.
StackIQ has announced the release of Stacki 3.2. Stacki is an easy-to-use Linux server provisioning tool. Stacki 3.2 delivers new capabilities that simplify the automation and integration of site-specific requirements. StackIQ is the commercial entity behind this open source bare metal provisioning tool. Since the release of Stacki in June of 2015, the Stacki core team has been focused on making the Community Edition meet the needs of members of the community, adding features and value, while ...
Qosmos has announced new milestones in the detection of encrypted traffic and in protocol signature coverage. Qosmos latest software can accurately classify traffic encrypted with SSL/TLS (e.g., Google, Facebook, WhatsApp), P2P traffic (e.g., BitTorrent, MuTorrent, Vuze), and Skype, while preserving the privacy of communication content. These new classification techniques mean that traffic optimization, policy enforcement, and user experience are largely unaffected by encryption. In respect wit...
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
SYS-CON Events announced today the Kubernetes and Google Container Engine Workshop, being held November 3, 2016, in conjunction with @DevOpsSummit at 19th Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA. This workshop led by Sebastian Scheele introduces participants to Kubernetes and Google Container Engine (GKE). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, students learn the key concepts and practices for deploying and maintainin...
SYS-CON Events announced today that Venafi, the Immune System for the Internet™ and the leading provider of Next Generation Trust Protection, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Venafi is the Immune System for the Internet™ that protects the foundation of all cybersecurity – cryptographic keys and digital certificates – so they can’t be misused by bad guys in attacks...
ReadyTalk has expanded the capabilities of the FoxDen collaboration platform announced late last year to include FoxDen Connect, an in-room video collaboration experience that launches with a single touch. With FoxDen Connect, users can now not only engage in HD video conferencing between iOS and Android mobile devices or Chrome browsers, but also set up in-person meeting rooms for video interactions. A host’s mobile device automatically recognizes the presence of a meeting room via beacon tech...
The cloud market growth today is largely in public clouds. While there is a lot of spend in IT departments in virtualization, these aren’t yet translating into a true “cloud” experience within the enterprise. What is stopping the growth of the “private cloud” market? In his general session at 18th Cloud Expo, Nara Rajagopalan, CEO of Accelerite, explored the challenges in deploying, managing, and getting adoption for a private cloud within an enterprise. What are the key differences between wh...
Deploying applications in hybrid cloud environments is hard work. Your team spends most of the time maintaining your infrastructure, configuring dev/test and production environments, and deploying applications across environments – which can be both time consuming and error prone. But what if you could automate provisioning and deployment to deliver error free environments faster? What could you do with your free time?
Ixia (Nasdaq: XXIA) has announced that NoviFlow Inc.has deployed IxNetwork® to validate the company’s designs and accelerate the delivery of its proven, reliable products. Based in Montréal, NoviFlow Inc. supports network carriers, hyperscale data center operators, and enterprises seeking greater network control and flexibility, network scalability, and the capacity to handle extremely large numbers of flows, while maintaining maximum network performance. To meet these requirements, NoviFlow in...
Choosing the right cloud for your workloads is a balancing act that can cost your organization time, money and aggravation - unless you get it right the first time. Economics, speed, performance, accessibility, administrative needs and security all play a vital role in dictating your approach to the cloud. Without knowing the right questions to ask, you could wind up paying for capacity you'll never need or underestimating the resources required to run your applications.
It’s 2016: buildings are smart, connected and the IoT is fundamentally altering how control and operating systems work and speak to each other. Platforms across the enterprise are networked via inexpensive sensors to collect massive amounts of data for analytics, information management, and insights that can be used to continuously improve operations. In his session at @ThingsExpo, Brian Chemel, Co-Founder and CTO of Digital Lumens, will explore: The benefits sensor-networked systems bring to ...